Weight care
Tirzepatide
A dual-pathway weight-management program for people reviewed and approved by a licensed clinician.
$249/month
All-inclusive program price · Illustrative pricing
Product imagery is intended solely for illustrative purposes. Actual medication packaging and pharmacy labeling may differ.
Weight care
Semaglutide
A GLP-1 based weight-management program with licensed-provider review, ongoing support, and one clear monthly price.
$149/month
All-inclusive program price · Illustrative pricing
- Online licensed-provider review
- Secure medical intake after checkout
- Ongoing program support by secure message
- Standard shipping
- Routine follow-up required by the program
May be compounded — not FDA-approved
Available in eligible states. Availability varies by program and pharmacy coverage.
VitaWellRx® notice. VitaWellRx® is a telehealth platform that connects eligible patients with independent US-licensed providers and licensed pharmacy partners. VitaWellRx® is not a pharmacy and does not itself practice medicine. Prescription products are provided only if clinically appropriate after review by a US-licensed provider.
About this program
The VitaWellRx® Semaglutide program is a clinician-guided weight-management program. You choose the program and complete checkout first; the required secure medical intake follows, and a licensed clinician then decides whether treatment is medically appropriate for you.
Semaglutide belongs to a class of medicines known as GLP-1 receptor agonists. Branded semaglutide products have been approved by the FDA for specific indications. Not every semaglutide formulation available through telehealth is the same as an FDA-approved branded product — compounded formulations are different products, and where a compounded formulation would be used, that is disclosed before fulfilment.
Care is delivered asynchronously by default. You submit your intake, identification, and any requested information, and a clinician reviews it on their own schedule.
People commonly considered for review include adults with weight-related health goals who can safely be managed remotely. Provider judgment governs.
How it may work
GLP-1 receptor agonists act on pathways involved in appetite signalling and gastric emptying. In general terms, that is why people in clinical settings often report feeling full sooner and staying full longer.
The effect is not automatic and is not identical between people. VitaWellRx® does not publish dosing instructions or self-administration guidance on this website.
Product status
- Semaglutide is an active ingredient present in FDA-approved branded products for specific indications.
- The program shown here may involve a compounded formulation. A compounded product is not the same as an FDA-approved branded drug.
- Any program would be used only where clinically and legally appropriate.
Eligibility and provider review
Tell your reviewing clinician about personal or family history of medullary thyroid carcinoma or MEN 2, pancreatitis, gallbladder disease, diabetic retinopathy, severe gastrointestinal disease, pregnancy or breastfeeding, and every medication and supplement you take.
Prescription required. Licensed-provider review required. Not everyone qualifies.
Safety summary
- Commonly described side effects of GLP-1 medicines include nausea, vomiting, diarrhoea, constipation, and abdominal discomfort, particularly early in a program.
- Serious risks have been described with this class, including pancreatitis, gallbladder problems, kidney injury related to dehydration, and low blood sugar when combined with certain diabetes medicines.
- This is a high-level summary and not a complete list. Stop and seek immediate care for severe abdominal pain, persistent vomiting, or signs of an allergic reaction.